Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?
about
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in ChildrenReplication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant.Replication of associations between genetic polymorphisms and chronic graft-versus-host disease.Exomechip Analyses Identify Genes Affecting Mortality after HLA-Matched Unrelated Donor Blood and Marrow Transplantation.
P2860
Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Identification and utilization ...... T: are we ready for primetime?
@ast
Identification and utilization ...... T: are we ready for primetime?
@en
Identification and utilization ...... T: are we ready for primetime?
@nl
type
label
Identification and utilization ...... T: are we ready for primetime?
@ast
Identification and utilization ...... T: are we ready for primetime?
@en
Identification and utilization ...... T: are we ready for primetime?
@nl
prefLabel
Identification and utilization ...... T: are we ready for primetime?
@ast
Identification and utilization ...... T: are we ready for primetime?
@en
Identification and utilization ...... T: are we ready for primetime?
@nl
P2093
P2860
P921
P1476
Identification and utilization ...... T: are we ready for primetime?
@en
P2093
Alyssa Clay
Kenan Onel
Lara E. Sucheston-Campbell
Leah Preus
Marcelo Pasquini
Philip L. McCarthy
Qianqian Zhu
Theresa Hahn
P2860
P2888
P356
10.1007/S11899-014-0246-X
P407
P577
2015-03-01T00:00:00Z
P5875
P6179
1036530312